{"id":"https://openalex.org/W2043916060","doi":"https://doi.org/10.1254/fpj.105.243","title":"Hemodynamic and neurohumoral effects of carperitide (.ALPHA.-human atrial natriuretic peptide) in dogs with low-output heart failure.","display_name":"Hemodynamic and neurohumoral effects of carperitide (.ALPHA.-human atrial natriuretic peptide) in dogs with low-output heart failure.","publication_year":1995,"publication_date":"1995-01-01","ids":{"openalex":"https://openalex.org/W2043916060","doi":"https://doi.org/10.1254/fpj.105.243","mag":"2043916060","pmid":"https://pubmed.ncbi.nlm.nih.gov/7774861"},"language":"ja","primary_location":{"id":"doi:10.1254/fpj.105.243","doi":"https://doi.org/10.1254/fpj.105.243","is_oa":false,"landing_page_url":"https://doi.org/10.1254/fpj.105.243","pdf_url":null,"source":{"id":"https://openalex.org/S156890813","display_name":"Folia Pharmacologica Japonica","issn_l":"0015-5691","issn":["0015-5691","0369-4461","1347-8397","2185-307X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Folia Pharmacologica Japonica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113602349","display_name":"Toshinori Hidaka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122276","display_name":"Suntory (Japan)","ror":"https://ror.org/02jg1fa85","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210122276"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshinori HIDAKA","raw_affiliation_strings":["Suntory Institute for Biomedical Research, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suntory Institute for Biomedical Research, Osaka, Japan","institution_ids":["https://openalex.org/I4210122276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111725185","display_name":"Mayumi Furuya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mayumi FURUYA","raw_affiliation_strings":["\u30b5\u30f3\u30c8\u30ea\u30fc(\u682a)\u751f\u7269\u533b\u5b66\u7814\u7a76\u6240\u30fb\u5275\u85ac\u7b2c2\u7814\u7a76\u6240"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u30b5\u30f3\u30c8\u30ea\u30fc(\u682a)\u751f\u7269\u533b\u5b66\u7814\u7a76\u6240\u30fb\u5275\u85ac\u7b2c2\u7814\u7a76\u6240","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102288777","display_name":"Yoshihiro Tani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshihiro TANI","raw_affiliation_strings":["\u30b5\u30f3\u30c8\u30ea\u30fc(\u682a)\u751f\u7269\u533b\u5b66\u7814\u7a76\u6240\u30fb\u5275\u85ac\u7b2c2\u7814\u7a76\u6240"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u30b5\u30f3\u30c8\u30ea\u30fc(\u682a)\u751f\u7269\u533b\u5b66\u7814\u7a76\u6240\u30fb\u5275\u85ac\u7b2c2\u7814\u7a76\u6240","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103416706","display_name":"Tomochika Ohno","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomochika OHNO","raw_affiliation_strings":["\u30b5\u30f3\u30c8\u30ea\u30fc(\u682a)\u751f\u7269\u533b\u5b66\u7814\u7a76\u6240\u30fb\u5275\u85ac\u7b2c2\u7814\u7a76\u6240"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u30b5\u30f3\u30c8\u30ea\u30fc(\u682a)\u751f\u7269\u533b\u5b66\u7814\u7a76\u6240\u30fb\u5275\u85ac\u7b2c2\u7814\u7a76\u6240","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":94},"biblio":{"volume":"105","issue":"4","first_page":"243","last_page":"261"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14486","display_name":"Cardiovascular, Neuropeptides, and Oxidative Stress Research","score":0.0071000000461936,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carperitide","display_name":"carperitide","score":1.0},{"id":"https://openalex.org/keywords/alpha-human-atrial-natriuretic-peptide","display_name":"alpha-human atrial natriuretic peptide","score":0.9210000038146973},{"id":"https://openalex.org/keywords/low-output-heart-failure","display_name":"low-output heart failure","score":0.9909999966621399},{"id":"https://openalex.org/keywords/hemodynamic-effects","display_name":"hemodynamic effects","score":0.7739999890327454},{"id":"https://openalex.org/keywords/cgmp","display_name":"cyclic GMP","score":0.8569999933242798},{"id":"https://openalex.org/keywords/nitroglycerin","display_name":"nitroglycerin","score":0.8009999990463257},{"id":"https://openalex.org/keywords/preload-reduction","display_name":"preload reduction","score":0.675000011920929},{"id":"https://openalex.org/keywords/afterload-reduction","display_name":"afterload reduction","score":0.9959999918937683},{"id":"https://openalex.org/keywords/plasma-renin-activity","display_name":"plasma renin activity","score":0.7419999837875366},{"id":"https://openalex.org/keywords/aldosterone","display_name":"aldosterone","score":0.7900000214576721},{"id":"https://openalex.org/keywords/norepinephrine","display_name":"norepinephrine","score":0.9649999737739563},{"id":"https://openalex.org/keywords/coronary-artery-ligation","display_name":"coronary artery ligation","score":0.7609999775886536},{"id":"https://openalex.org/keywords/methoxamine","display_name":"methoxamine","score":0.7879999876022339}],"concepts":[{"id":"https://openalex.org/C2778069365","wikidata":"https://www.wikidata.org/wiki/Q78185357","display_name":"Atrial natriuretic peptide","level":2,"score":0.7114577293395996},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6926841735839844},{"id":"https://openalex.org/C48277249","wikidata":"https://www.wikidata.org/wiki/Q1406926","display_name":"Preload","level":3,"score":0.6892508268356323},{"id":"https://openalex.org/C2780745239","wikidata":"https://www.wikidata.org/wiki/Q685119","display_name":"Methoxamine","level":4,"score":0.6739542484283447},{"id":"https://openalex.org/C138976137","wikidata":"https://www.wikidata.org/wiki/Q7201790","display_name":"Plasma renin activity","level":4,"score":0.6680426597595215},{"id":"https://openalex.org/C178853913","wikidata":"https://www.wikidata.org/wiki/Q1642137","display_name":"Hemodynamics","level":2,"score":0.6228236556053162},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6037981510162354},{"id":"https://openalex.org/C123576724","wikidata":"https://www.wikidata.org/wiki/Q1299082","display_name":"Afterload","level":3,"score":0.5618661642074585},{"id":"https://openalex.org/C2778525890","wikidata":"https://www.wikidata.org/wiki/Q184564","display_name":"Aldosterone","level":2,"score":0.5339402556419373},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.5175630450248718},{"id":"https://openalex.org/C139940330","wikidata":"https://www.wikidata.org/wiki/Q596579","display_name":"Cardiac output","level":3,"score":0.5136372447013855},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.4926465153694153},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.4322347044944763},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3910461664199829},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.3428493142127991},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002303","descriptor_name":"Cardiac Output, Low","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002303","descriptor_name":"Cardiac Output, Low","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004231","descriptor_name":"Diuresis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005996","descriptor_name":"Nitroglycerin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006152","descriptor_name":"Cyclic GMP","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006439","descriptor_name":"Hemodynamics","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008729","descriptor_name":"Methoxamine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009320","descriptor_name":"Atrial Natriuretic Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1254/fpj.105.243","doi":"https://doi.org/10.1254/fpj.105.243","is_oa":false,"landing_page_url":"https://doi.org/10.1254/fpj.105.243","pdf_url":null,"source":{"id":"https://openalex.org/S156890813","display_name":"Folia Pharmacologica Japonica","issn_l":"0015-5691","issn":["0015-5691","0369-4461","1347-8397","2185-307X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Folia Pharmacologica Japonica","raw_type":"journal-article"},{"id":"pmid:7774861","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7774861","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nihon yakurigaku zasshi. Folia pharmacologica Japonica","raw_type":"English Abstract"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1912252476","https://openalex.org/W1971654317","https://openalex.org/W1986114415","https://openalex.org/W2002730049","https://openalex.org/W2005257617","https://openalex.org/W2007574712","https://openalex.org/W2018073400","https://openalex.org/W2018573712","https://openalex.org/W2024494699","https://openalex.org/W2047202581","https://openalex.org/W2052910789","https://openalex.org/W2068631477","https://openalex.org/W2072744826","https://openalex.org/W2075842226","https://openalex.org/W2082370756","https://openalex.org/W2084418892","https://openalex.org/W2106417503","https://openalex.org/W2209840865","https://openalex.org/W2295863437","https://openalex.org/W2411728052","https://openalex.org/W2415200882","https://openalex.org/W2416142089","https://openalex.org/W2515618388"],"related_works":["https://openalex.org/W2515618388","https://openalex.org/W3100939154","https://openalex.org/W1979413810","https://openalex.org/W2327442345","https://openalex.org/W2031619028","https://openalex.org/W1976562229","https://openalex.org/W2049971658","https://openalex.org/W3106512385","https://openalex.org/W2105445309","https://openalex.org/W2087772143"],"abstract_inverted_index":{"We":[0],"examined":[1],"the":[2,22,71,148],"hemodynamic":[3,150],"and":[4,28,48,52,102,122,135,146],"neurohumoral":[5],"effects":[6,114],"of":[7,21,63,70,79,90,100],"carperitide":[8,108,131],"in":[9,137,142,152],"dogs":[10],"with":[11,107,139],"low-output":[12],"heart":[13],"failure":[14],"(LHF)":[15],"produced":[16],"by":[17,98],"volume":[18],"expansion,":[19],"ligation":[20],"left":[23],"anterior":[24],"descending":[25],"coronary":[26],"artery":[27],"methoxamine":[29],"infusion.":[30],"Carperitide":[31,111],"(0.1":[32],"approximately":[33],"1":[34],"micrograms/kg/min,":[35],"i.v.":[36],"infusion":[37],"for":[38],"30":[39],"min)":[40],"decreased":[41],"pulmonary":[42],"arterial":[43],"pressure,":[44],"right":[45],"atrial":[46],"pressure":[47],"systemic":[49],"vascular":[50],"resistance":[51],"increased":[53,84,104],"cardiac":[54],"output.":[55],"These":[56,125],"pharmacological":[57],"activities":[58],"were":[59],"equivalent":[60],"to":[61],"those":[62],"nitroglycerin":[64],"(NG,":[65],"3":[66],"micrograms/kg/min).":[67],"Although":[68],"most":[69],"animals":[72],"did":[73],"not":[74],"excrete":[75],"urine":[76,85],"after":[77,105],"induction":[78,99],"LHF,":[80],"carperitide,":[81],"unlike":[82],"NG,":[83],"volume.":[86],"The":[87],"plasma":[88,116,119,123],"level":[89],"cyclic":[91,143],"GMP":[92,144],"was":[93],"elevated":[94],"about":[95],"three":[96],"times":[97],"LHF":[101,153],"further":[103],"treatment":[106],"(1":[109],"microgram/kg/min).":[110],"had":[112],"no":[113],"on":[115],"renin":[117],"activity,":[118],"aldosterone":[120],"concentration":[121],"noradrenaline.":[124],"results":[126],"taken":[127],"together":[128],"indicate":[129],"that":[130],"reduces":[132],"both":[133],"preload":[134],"afterload":[136],"association":[138],"an":[140],"increase":[141],"production":[145],"improves":[147],"untoward":[149],"alterations":[151],"dogs.":[154]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2016-06-24T00:00:00"}